NO971332L - Fremstilling av krystallinsk penem - Google Patents

Fremstilling av krystallinsk penem

Info

Publication number
NO971332L
NO971332L NO971332A NO971332A NO971332L NO 971332 L NO971332 L NO 971332L NO 971332 A NO971332 A NO 971332A NO 971332 A NO971332 A NO 971332A NO 971332 L NO971332 L NO 971332L
Authority
NO
Norway
Prior art keywords
preparation
crystallization
accomplished
maintaining
smaller
Prior art date
Application number
NO971332A
Other languages
English (en)
Other versions
NO971332D0 (no
Inventor
Masayoshi Kaneko
Shigeo Yabuno
Original Assignee
Lederle Japan Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO971332L publication Critical patent/NO971332L/no
Application filed by Lederle Japan Ltd, Takeda Chemical Industries Ltd filed Critical Lederle Japan Ltd
Publication of NO971332D0 publication Critical patent/NO971332D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Fremgangsmåte for krystallisering av (lR,5S,6S)-2- [(6 ,7-dlhydro-5H-pyrazolo[l,2-a] [1, 2 ,4]t^iazolluIn-6- yl )]tlo-6-C(R)-l-hydroksyetyl]-l-metyl-karbapenem-3- karboksylat (heretter forkortet som L-627), og er kjennetegnet ved at man opprettholder en vandig oppløsning med L-627 ved temperaturer 1 oppløsningen 1 området fra eutektlsk temperatur til temperaturer lavere enn 0*C. Fremgangsmåten medfører noen fordeler ved at tap av L- 627 som følge av krystallisasjon er mindre, antall trinn i fremstillingen av beholderformuleringene er mindre og opprettholdelse av disse trinnene under sterile og støvfrie betingelser kan enkelt bil gjennomfart, dlspenserlng av medikamentet kan bli gjennomført med kvantitativ nøyaktighet, og krystallene oppløses i et oppløsningsmiddel øyeblikkelig på anvendelsestidspunktet.
NO971332A 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem NO971332D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24164891 1991-09-20

Publications (2)

Publication Number Publication Date
NO971332L true NO971332L (no) 1993-03-22
NO971332D0 NO971332D0 (no) 1997-03-21

Family

ID=17077445

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92923619A NO923619L (no) 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem
NO971332A NO971332D0 (no) 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92923619A NO923619L (no) 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem

Country Status (9)

Country Link
US (2) US5286856A (no)
EP (1) EP0533149A1 (no)
JP (1) JP2767171B2 (no)
KR (1) KR930006022A (no)
FI (1) FI924210A (no)
IL (1) IL103218A0 (no)
NO (2) NO923619L (no)
TW (1) TW264475B (no)
ZA (1) ZA927164B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW264475B (no) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
AU749234B2 (en) * 1998-03-02 2002-06-20 Merck Sharp & Dohme Corp. Process for synthesizing carbapenem antibiotics
DE10300620B4 (de) * 2002-05-18 2017-04-13 Carl Zeiss Meditec Ag Trägervorrichtung für ein medizinisch-optisches Gerät
KR101013535B1 (ko) * 2004-10-21 2011-02-14 주식회사 만도 자동차의 파워 스티어링 장치용 실린더 튜브와 피드튜브의 조립 구조물
BRPI0717107A2 (pt) 2006-09-25 2013-10-15 Ptc Therapeutics Inc FORMA DE CRISTAL, FORMA DE DOSAGEM FARMACÊUTICA, E, MÉTODO PARA MODULAR TERMINAÇÃO DE TRANSLAÇÃO PREMATURA OU DETERIORAÇÃO DE mRNA
US8293924B2 (en) * 2007-10-08 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
DE102008043318A1 (de) 2008-10-30 2010-05-12 Mvg Metallverarbeitungsgesellschaft Mbh Anhängekupplung
WO2013132422A1 (en) * 2012-03-05 2013-09-12 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of carbapenem antibiotic
ES2758507T3 (es) 2012-05-30 2020-05-05 Meiji Seika Pharma Co Ltd Nuevo inhibidor de B-lactamasa y método para producir el mismo
WO2014097221A1 (en) 2012-12-21 2014-06-26 Ranbaxy Laboratories Limited Process for the purification of biapenem
RU2719480C2 (ru) 2013-09-24 2020-04-17 Мейдзи Сейка Фарма Ко., Лтд. Способ получения производного диазабициклооктана и его промежуточного соединения
ES2901198T3 (es) 2013-10-08 2022-03-21 Meiji Seika Pharma Co Ltd Formas cristalinas de derivado de diazabiciclooctano y procedimiento de producción de las mismas
KR102555657B1 (ko) 2014-12-05 2023-07-18 메이지 세이카 파루마 가부시키가이샤 디아자비시클로옥탄 유도체의 결정 및 안정된 동결 건조 제제의 제조법
CN114349772B (zh) * 2020-10-13 2022-11-25 珠海联邦制药股份有限公司 一种比阿培南粗品的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
JPS6024080B2 (ja) * 1977-06-01 1985-06-11 武田薬品工業株式会社 結晶の製造法
GB1589317A (en) * 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS56120615A (en) * 1980-02-27 1981-09-22 Nippon Chemiphar Co Ltd Preparation of lyophilized powder of cephalothin
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US4866171A (en) * 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
JPS6425779A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
GB9021061D0 (en) * 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
TW264475B (no) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
ATE201877T1 (de) * 1993-01-29 2001-06-15 Agouron Pharma Kondensierte heterocyclische glutaminsäurederivate als antiproliferative mittel

Also Published As

Publication number Publication date
NO923619D0 (no) 1992-09-17
IL103218A0 (en) 1993-02-21
US5286856A (en) 1994-02-15
ZA927164B (en) 1994-03-18
FI924210A (fi) 1993-03-21
JP2767171B2 (ja) 1998-06-18
NO971332D0 (no) 1997-03-21
AU2459792A (en) 1993-03-25
KR930006022A (ko) 1993-04-20
US5424069A (en) 1995-06-13
JPH05271241A (ja) 1993-10-19
AU645442B2 (en) 1994-01-13
FI924210A0 (fi) 1992-09-18
EP0533149A1 (en) 1993-03-24
TW264475B (no) 1995-12-01
NO923619L (no) 1993-03-22

Similar Documents

Publication Publication Date Title
NO971332L (no) Fremstilling av krystallinsk penem
CN104644640B (zh) 一种注射用头孢哌酮钠舒巴坦钠粉针的制备方法
JPS6434986A (en) Production of carbapenem compound in crystal form
AU2001261079B2 (en) Process for formulation of antibiotic compounds
ATE223916T1 (de) Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
ATE24488T1 (de) 3-hydroxypyrrolidin-2-on-derivate, verfahren und zwischenprodukte zu deren herstellung und diese enthaltende arzneimittel.
AU2001261079A1 (en) Process for formulation of antibiotic compounds
DK48983A (da) Fremgangsmaade til fremstilling af substituerede dibenzodiazepinoner
FI103576B1 (fi) Menetelmä lääkeaineena käyttökelpoisen kiteisen karbapeneemijohdannaisen valmistamiseksi
NO176102C (no) Fremgangsmåte ved fremstilling av carbapenemderivater og deres utgangsmaterialer
CA2746682C (en) Process for the preparation of antibiotic compounds
US20020002160A1 (en) Process for formulation of antibiotic compounds
JPH0459730A (ja) セフェム系抗生物質含有凍結乾燥製剤
GR1002251B (en) Process for preparing clystalline (5r,6s)-2-carbamouloxymethyl-6-£(1r)-hydroxyethyl|-2-penem-carboxylic acid and its pharmaceutical formulation
DK411488D0 (da) (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaader til deres fremstilling samt deres anvendelse
Sato et al. Stereochemistry of seven-membered-ring compounds: X-ray analysis of dextrorotatory 4-bromo-6, 10-dimethylbicyclo [5, 3, 0] decan-3-one
JPS61129123A (ja) カルバペネム誘導体の安定な凍結乾燥製剤の製造法
ES8402302A1 (es) Un procedimiento para la preparacion de derivados de 7-oxo-1-azabiciclo (3,2-0) hepteno.
JPS594416B2 (ja) フエニレフリンルイノ アンテイカホウ
TH10195B (th) อนุพันธ์คาร์แบเพแนมซึ่งเป็นผลึก
CN1086315A (zh) 食品卫生检测标准溶液安瓿制剂生产方法